Literature DB >> 21289146

Chronic Q fever-related dual-pathogen endocarditis: case series of three patients.

Linda M Kampschreur1, Jan Jelrik Oosterheert, Cornelia A de Vries Feyens, Corine E Delsing, Mirjam H A Hermans, Ingrid L L van Sluisveld, Peter J Lestrade, Nicole H M Renders, Peter Elsman, Peter C Wever.   

Abstract

Following Coxiella burnetii infection, there is a 1 to 5% risk of chronic Q fever. Endocarditis, mycotic aneurysm, and vascular prosthesis infection are common manifestations. We present three patients with endocarditis by C. burnetii concomitant with another bacterial pathogen. Chronic Q fever should therefore be considered in all endocarditis patients in regions where Q fever is endemic.

Entities:  

Mesh：

Year:  2011        PMID： 21289146      PMCID： PMC3122851          DOI： 10.1128/JCM.02596-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  12 in total

1.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

Authors:  J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey
Journal:  Clin Infect Dis       Date:  2000-04-03       Impact factor: 9.079

Review 2.  Natural history and pathophysiology of Q fever.

Authors:  D Raoult; Tj Marrie; Jl Mege
Journal:  Lancet Infect Dis       Date:  2005-04       Impact factor: 25.071

Review 3.  Q fever.

Authors:  Neil R Parker; Jennifer H Barralet; Alan Morton Bell
Journal:  Lancet       Date:  2006-02-25       Impact factor: 79.321

4.  Risks factors and prevention of Q fever endocarditis.

Authors:  F Fenollar; P E Fournier; M P Carrieri; G Habib; T Messana; D Raoult
Journal:  Clin Infect Dis       Date:  2001-06-25       Impact factor: 9.079

5.  Incidental live-saving polymerase chain reaction in a case of prosthetic valve dual-pathogen endocarditis.

Authors:  C Kaech; D Raoult; G Greub
Journal:  Clin Infect Dis       Date:  2008-07-01       Impact factor: 9.079

6.  Coinfection with Coxiella burnetii in infectious endocarditis.

Authors:  C Rovery; B Granel; J-P Casalta; H Lepidi; G Habib; D Raoult
Journal:  Clin Microbiol Infect       Date:  2009-06-22       Impact factor: 8.067

7.  Contribution of systematic serological testing in diagnosis of infective endocarditis.

Authors:  D Raoult; J P Casalta; H Richet; M Khan; E Bernit; C Rovery; S Branger; F Gouriet; G Imbert; E Bothello; F Collart; G Habib
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

8.  Q fever in the Netherlands: an update on the epidemiology and control measures.

Authors:  W van der Hoek; F Dijkstra; B Schimmer; P M Schneeberger; P Vellema; C Wijkmans; R ter Schegget; V Hackert; Y van Duynhoven
Journal:  Euro Surveill       Date:  2010-03-25

9.  Molecular detection of Coxiella burnetii in the sera of patients with Q fever endocarditis or vascular infection.

Authors:  F Fenollar; P E Fournier; D Raoult
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

10.  Long-term outcome of Q fever endocarditis: a 26-year personal survey.

Authors:  Matthieu Million; Franck Thuny; Hervé Richet; Didier Raoult
Journal:  Lancet Infect Dis       Date:  2010-07-14       Impact factor: 25.071
View more
  2 in total

1.  Microbiological challenges in the diagnosis of chronic Q fever.

Authors:  Linda M Kampschreur; Jan Jelrik Oosterheert; Annemarie M C Koop; Marjolijn C A Wegdam-Blans; Corine E Delsing; Chantal P Bleeker-Rovers; Monique G L De Jager-Leclercq; Cornelis A R Groot; Tom Sprong; Marrigje H Nabuurs-Franssen; Nicole H M Renders; Marjo E van Kasteren; Yvonne Soethoudt; Sybrandus N Blank; Marjolijn J H Pronk; Rolf H H Groenwold; Andy I M Hoepelman; Peter C Wever
Journal:  Clin Vaccine Immunol       Date:  2012-03-21

2.  Q fever endocarditis in Romania: the first cases confirmed by direct sequencing.

Authors:  Ani Ioana Cotar; Daniela Badescu; Mihaela Oprea; Sorin Dinu; Otilia Banu; Dan Dobreanu; Minodora Dobreanu; Adina Ionac; Mirela Flonta; Monica Straut
Journal:  Int J Mol Sci       Date:  2011-12-20       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.